Comprehensive targeted and non-targeted lipidomics analyses in failing and non-failing heart

Ganesh V Halade1, Anela Dorbane2, Kevin A Ingle3

  • 1Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, 703 19th Street South, MC7755, Birmingham, AL, 35294, USA. ganeshhalade@uabmc.edu.

Insights

Myocardial infarction triggers inflammation and the formation of lipid-resolving molecules in the heart. These bioactive lipids are crucial for resolving inflammation and improving heart failure post-infarction.

Area of Science:

  • Cardiovascular Biology
  • Lipidomics
  • Inflammation Research

Background:

  • Myocardial infarction (MI) and heart failure are leading global causes of death.
  • The precise mechanisms underlying post-MI heart failure pathology remain incompletely understood.
  • Inflammatory responses play a critical role in cardiac injury and repair post-MI.

Purpose of the Study:

  • To investigate the role of bioactive lipid-resolving molecules at the site of myocardial injury post-MI.
  • To test the hypothesis that inflammation resolution involves specific lipid mediators in acute heart failure.
  • To characterize the spatial distribution and changes in cardiac lipids following myocardial infarction.

Main Methods:

  • Induction of myocardial infarction using a permanent coronary ligation model in rodents.
  • Mass spectrometry imaging (MSI) in positive and negative ionization modes to analyze lipid distribution.
  • Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) for lipid structure confirmation.
  • Principal component analysis (PCA) for comprehensive visualization of lipid profile alterations.

Main Results:

  • MI induced decreased contractility, wall thinning, and necrosis in the left ventricle.
  • MSI detected inflammation-resolving bioactive molecules (e.g., resolvins) and phosphatidylcholines in the infarcted myocardium.
  • Significant increases in resolvin lipids and comprehensive lipid remodeling were observed at the infarction site.
  • Lipid profiles differed significantly between MI and non-MI hearts.

Conclusions:

  • The infarcted myocardium is a key site for inflammation-resolution pathomechanics.
  • Bioactive lipid-resolving molecules are critical for resolving inflammation and mitigating heart failure pathophysiology post-MI.
  • Lipidomic analysis provides crucial insights into the molecular mechanisms of cardiac injury and repair.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.6K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
8
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
18
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
16